相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alginate oligosaccharide alleviates senile osteoporosis via the RANKL-RANK pathway in D-galactose-induced C57BL/6J mice
Shan Wang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2022)
UK clinical guideline for the prevention and treatment of osteoporosis
Celia L. Gregson et al.
ARCHIVES OF OSTEOPOROSIS (2022)
Glycyrrhizin improves bone metabolism in ovariectomized mice via inactivating NF-κB signaling
Y. Tang et al.
CLIMACTERIC (2021)
Chitooligosaccharide inhibits RANKL-induced osteoclastogenesis and ligation-induced periodontitis by suppressing MAPK/ c-fos/NFATC1 signaling
Weifeng Xu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Tectoridin inhibits osteoclastogenesis and bone loss in a murine model of ovariectomy-induced osteoporosis
Jirong Wang et al.
EXPERIMENTAL GERONTOLOGY (2020)
Osteoclast Multinucleation: Review of Current Literature
Joe Kodama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Prospect of Stem Cell Therapy and Regenerative Medicine in Osteoporosis
Babak Arjmand et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Inhibition of glucuronomannan hexamer on the proliferation of lung cancer through binding with immunoglobulin G
Weihua Jin et al.
CARBOHYDRATE POLYMERS (2020)
Inactivating Mutation in IRF8 Promotes Osteoclast Transcriptional Programs and Increases Susceptibility to Tooth Root Resorption
Vivek Thumbigere-Math et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Ecklonia cava Extract Containing Dieckol Suppresses RANKL-Induced Osteoclastogenesis via MAP Kinase/NF-κB Pathway Inhibition and Heme Oxygenase-1 Induction
Seonyoung Kim et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2019)
Fucoidan Prevents RANKL-Stimulated Osteoclastogenesis and LPS-Induced Inflammatory Bone Loss via Regulation of Akt/GSK3β/PTEN/NFATc1 Signaling Pathway and Calcineurin Activity
Sheng-Hua Lu et al.
MARINE DRUGS (2019)
Therapeutic Effects of Fucoidan: A Review on Recent Studies
Sibusiso Luthuli et al.
MARINE DRUGS (2019)
Denosumab in the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Zeina A. Yanbeiy et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
IRF8 induces senescence of lung cancer cells to exert its tumor suppressive function
Jinxia Liang et al.
CELL CYCLE (2019)
Chitosan oligosaccharide inhibits skull resorption induced by lipopolysaccharides in mice
Ke Guo et al.
BMC ORAL HEALTH (2019)
Madecassoside inhibits estrogen deficiency-induced osteoporosis by suppressing RANKL-induced osteoclastogenesis
Qingqing Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
RANKL-independent modulation of osteoclastogenesis
Wei Feng et al.
JOURNAL OF ORAL BIOSCIENCES (2019)
Mechanisms involved in normal and pathological osteoclastogenesis
Kyung-Hyun Park-Min
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Osteoclast-Derived Extracellular Vesicles: Novel Regulators of Osteoclastogenesis and Osteoclast-Osteoblasts Communication in Bone Remodeling
Feng-Lai Yuan et al.
FRONTIERS IN PHYSIOLOGY (2018)
Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study
Kenneth G. Saag et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Regulation of Osteoclast Differentiation by Cytokine Networks
Dulshara Sachini Amarasekara et al.
IMMUNE NETWORK (2018)
Structural Features of Sulfated Glucuronomannan Oligosaccharides and Their Antioxidant Activity
Weihua Jin et al.
MARINE DRUGS (2018)
Low-molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats
Xin Jin et al.
MOLECULAR MEDICINE REPORTS (2017)
Orostachys japonicus Suppresses Osteoclast Differentiation by Inhibiting NFATc1 Expression
Ki-Shuk Shim et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2015)
IL-33 inhibits RANKL-induced osteoclast formation through the regulation of Blimp-1 and IRF-8 expression
Hiroyasu Kiyomiya et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Osteoporosis: the evolution of a diagnosis
M. Lorentzon et al.
JOURNAL OF INTERNAL MEDICINE (2015)
NF-κB-Mediated Regulation of Osteoclastogenesis
Brendan F. Boyce et al.
ENDOCRINOLOGY AND METABOLISM (2015)
Fucoidan, a Sulfated Polysaccharide, Inhibits Osteoclast Differentiation and Function by Modulating RANKL Signaling
Young Woo Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Brown seaweed fucoidan: Biological activity and apoptosis, growth signaling mechanism in cancer
Kalimuthu Senthilkumar et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2013)
Structural Analysis of a Heteropolysaccharide from Saccharina japonica by Electrospray Mass Spectrometry in Tandem with Collision-Induced Dissociation Tandem Mass Spectrometry (ESI-CID-MS/MS)
Weihua Jin et al.
MARINE DRUGS (2012)
Alginate oligosaccharide protects against endoplasmic reticulum- and mitochondrial-mediated apoptotic cell death and oxidative stress
Solaleh Khoramian Tusi et al.
BIOMATERIALS (2011)
Bone regeneration: current concepts and future directions
Rozalia Dimitriou et al.
BMC MEDICINE (2011)
Maslinic Acid Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Regulating RANKL-Mediated NF-κB and MAPK Signaling Pathways
Chenghai Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Bone anabolic versus bone anticatabolic treatment of postmenopausal osteoporosis
George P. Lyritis et al.
WOMEN'S HEALTH AND DISEASE (2010)
NF-κB modulators in osteolytic bone diseases
Jiake Xu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2009)
Bisphosphonate-associated adverse events
Peter D. Papapetrou
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2009)
Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis
Baohong Zhao et al.
NATURE MEDICINE (2009)
Inhibitory Effect of Fucoidan on Huh7 Hepatoma Cells Through Downregulation of CXCL12
Takeaki Nagamine et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2009)
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Hiroshi Takayanagi
NATURE REVIEWS IMMUNOLOGY (2007)
IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss
MG Ruocco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study
PD Delmas et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide
O Berteau et al.
GLYCOBIOLOGY (2003)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
JY Reginster et al.
OSTEOPOROSIS INTERNATIONAL (2000)
Therapeutic approaches to bone diseases
GA Rodan et al.
SCIENCE (2000)
分享论文
